Our data argue against the utility of IL-22 as specific biomarker for prevalent or incident type 2 diabetes in humans, but identify potential determinants of IL-22 levels which merits further research in the context of cardiovascular diseases. The gene discussed is IL22; the disease is type 2 diabetes mellitus.